Ignite Creation Date:
2024-05-05 @ 11:19 AM
Last Modification Date:
2024-10-26 @ 9:02 AM
Study NCT ID:
NCT00002184
Status:
COMPLETED
Last Update Posted:
2005-06-24
First Post:
1999-11-02
Brief Title:
A Phase II Stratified Randomized Double-Blind Multi-Center Study of the Safety and Efficacy of Adefovir Dipivoxil ADF at Two Dose Levels in Triple Combination Therapies With Protease Inhibitors PI and Nucleoside Reverse Transcriptase Inhibitors RTI for the Treatment of HIV-Infected Patient
Sponsor:
Gilead Sciences
Organization:
NIH AIDS Clinical Trials Information Service
Conditions & Keywords Data
Conditions:
| Name |
|---|
| HIV Infections |
Keywords:
| Name | View |
|---|---|
| HIV-1 | View |
| Dose-Response Relationship Drug | View |
| Drug Therapy Combination | View |
| Acquired Immunodeficiency Syndrome | View |
| Zidovudine | View |
| Stavudine | View |
| HIV Protease Inhibitors | View |
| CD4 Lymphocyte Count | View |
| Lamivudine | View |
| RNA Viral | View |
| Saquinavir | View |
| Nelfinavir | View |
| Reverse Transcriptase Inhibitors | View |
| Adenine | View |
| Anti-HIV Agents | View |
| Viral Load | View |